<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>atrial fibrillation &#8211; Michigan Brain &amp; Spine Surgery Center</title>
	<atom:link href="https://www.brainandspinesurgerycenter.com/tag/atrial-fibrillation-2/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.brainandspinesurgerycenter.com</link>
	<description></description>
	<lastBuildDate>Sun, 22 Feb 2015 22:09:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>

<image>
	<url>https://www.brainandspinesurgerycenter.com/wp-content/uploads/2010/10/lzamorano-small-120-85x85.jpg</url>
	<title>atrial fibrillation &#8211; Michigan Brain &amp; Spine Surgery Center</title>
	<link>https://www.brainandspinesurgerycenter.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Treat atrial fibrillation AF to prevent stroke</title>
		<link>https://www.brainandspinesurgerycenter.com/treat-atrial-fibrillation-af-to-prevent-stroke/</link>
		
		<dc:creator><![CDATA[Michigan Brain &#38; Spine]]></dc:creator>
		<pubDate>Mon, 05 Aug 2013 07:08:07 +0000</pubDate>
				<category><![CDATA[Stroke]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<guid isPermaLink="false">http://www.brainandspinesurgerycenter.com/?p=282</guid>

					<description><![CDATA[PRADAXA 150 mg twice daily provided an additional 35% risk reduction of stroke/systemic embolism vs warfarin Superior reduction of ischemic and hemorrhagic stroke vs warfarin Similar rate of major bleeds‡ with PRADAXA vs warfarin PRADAXA is the ONLY anticoagulant to demonstrate superior reduction of ischemic stroke vs warfarin PRADAXA also demonstrated a lower rate of...]]></description>
										<content:encoded><![CDATA[<p><a href="http://www.brainandspinesurgerycenter.com/wp-content/uploads/2013/08/pradaxa-stroke.jpg"><img decoding="async" class="alignright size-thumbnail wp-image-283" alt="pradaxa" src="http://www.brainandspinesurgerycenter.com/wp-content/uploads/2013/08/pradaxa-stroke-150x150.jpg" width="150" height="150" srcset="https://www.brainandspinesurgerycenter.com/wp-content/uploads/2013/08/pradaxa-stroke-150x150.jpg 150w, https://www.brainandspinesurgerycenter.com/wp-content/uploads/2013/08/pradaxa-stroke-85x85.jpg 85w" sizes="(max-width: 150px) 100vw, 150px" /></a>PRADAXA 150 mg twice daily provided an additional 35% risk reduction of stroke/systemic embolism vs warfarin</p>
<ul>
<li>Superior reduction of ischemic and hemorrhagic stroke vs warfarin</li>
<li>Similar rate of major bleeds<sup>‡</sup> with PRADAXA vs warfarin</li>
<li>PRADAXA is the ONLY anticoagulant to demonstrate superior reduction of ischemic stroke vs warfarin</li>
<li>PRADAXA also demonstrated a lower rate of intracranial bleeding vs warfarin</li>
</ul>
<p>Additional 35% risk reduction of stroke/systemic embolism vs warfarin. Protect the brain by reducing the risk of ischemic stroke.</p>
<p>Learn more at <a href="http://www.pradaxapro.com/" target="_blank">pradaxapro.com</a></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
